Vericel Insider Sold Shares Worth $1,526,350, According to a Recent SEC Filing-March 2024-www.financetom.com

Vericel Insider Sold Shares Worth $1,526,350, According to a Recent SEC Filing

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Vericel Insider Sold Shares Worth $1,526,350, According to a Recent SEC Filing

Jun 14, 2024 1:34 PM

04:13 PM EDT, 06/14/2024 (MT Newswires) -- Dominick Colangelo, Director, President and CEO, on June 12, 2024, sold 35,000 shares in Vericel ( VCEL ) for $1,526,350. Following the Form 4 filing with the SEC, Colangelo has control over a total of 220,752 shares of the company, with 220,752 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/887359/000114036124030179/xslF345X03/form4.xml

Previous page： Aluminum At Highs As Supply Squeeze Boosts Alcoa Outlook Next page： Form 8.3

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Aluminum At Highs As Supply Squeeze Boosts Alcoa Outlook

Mar 16, 2026

The global aluminum market is facing a convergence of geopolitical issues and persistent energy constraints. The result is the rally to multi-year highs that prompted analysts and investors to revise their price targets. The latest disruption was not unexpected. Bahrain's Alba has initiated a partial shutdown of its operations amid ongoing shipping disruptions. According to Reuters, the company said it...

Form 8.3

Mar 16, 2026

LONDON--(BUSINESS WIRE)-- FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: SAMSON ROCK CAPITAL LLP (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee...

Form 8.3

Mar 16, 2026

Acumen Pharmaceuticals to Raise $35.75 Million via Private Placement

Mar 16, 2026

07:11 AM EDT, 03/16/2026 (MT Newswires) -- Acumen Pharmaceuticals ( ABOS ) said Monday that it will raise about $35.75 million through a private placement, with each share priced at $3.30. The company said it signed a securities purchase agreement with certain investors led by RA Capital Management, with participation from ADAR1 Capital Management, Sands Capital, and a large investment...